84.2
Benjamin M. Yeh
University of California, San Francisco
Benjamin M. Yeh has made significant contributions to the development and application of intravascular contrast agents, oral dark borosilicate materials, and dual-energy CT (CT) technology in gastrointestinal imaging. Research highlights improved vascular contrast enhancement, conspicuity, and detection capabilities for malignant deposits using novel tantalum oxide-based agents and advanced spectral CT platforms. The study also explores the use of deep learning algorithms to differentiate premalignant from benign colorectal polyps, reducing peristalsis-related streak artifacts on liver images with dual-layer spectral CT, and identifying bismuth subsalicylate overdose in acute appendicitis via dual-energy CT.
Firms applying this knowledge
Kyoto University, Virginia Tech Intellectual Properties, Inc., General Electric Company, Dana-Farber Cancer Institute, Inc., Ptc Therapeutics, Inc., Medtronic Navigation, Inc., Van Andel Research Institute, Medical College Of Georgia Research Institute